EFNA4 is an inclusion criterion in 1 clinical trial for breast carcinoma, of which 0 are open and 1 is closed. Of the trial that contains EFNA4 status and breast carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

EFNA4 is an inclusion criterion in 1 clinical trial for fallopian tube carcinoma, of which 0 are open and 1 is closed. Of the trial that contains EFNA4 status and fallopian tube carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

EFNA4 is an inclusion criterion in 1 clinical trial for malignant solid tumor, of which 0 are open and 1 is closed. Of the trial that contains EFNA4 status and malignant solid tumor as inclusion criteria, 1 is phase 1 (0 open) [4].

EFNA4 is an inclusion criterion in 1 clinical trial for ovarian carcinoma, of which 0 are open and 1 is closed. Of the trial that contains EFNA4 status and ovarian carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

EFNA4 is an inclusion criterion in 1 clinical trial for primary peritoneal carcinoma, of which 0 are open and 1 is closed. Of the trial that contains EFNA4 status and primary peritoneal carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].